Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Rigotti

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Blood Purification|November 2, 2022
Anti-Inflammatory Approach in Chronic Dialysis Patients with SARS-CoV-2: ATA or PMMA Dialyzers?Gabriele Donati, Lorenzo Gasperoni, Marianna Napoli, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 2, 2019
C5 Convertase Blockade in Membranoproliferative Glomerulonephritis: A Single-Arm Clinical TrialPiero Ruggenenti, Erica Daina, Alessia Gennarini, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|September 21, 2018
[Challenges and results of the PIRP project (Prevenzione della Insufficienza Renale Progressiva) of the Emilia-Romagna Region]Antonio Santoro, Dino Gibertoni, Paola Rucci, et al.
Journal of Nephrology|January 20, 2019
The PIRP project (Prevenzione Insufficienza Renale Progressiva): how to integrate hospital and community maintenance treatment for chronic kidney diseaseAntonio Santoro, Dino Gibertoni, Paola Rucci, et al.
Nephron|April 26, 2021
COVID-19 Infection: Viral Clearance and Antibody Response in Dialysis Patients and Renal Transplant RecipientsPaolo Ferdinando Bruno, Maria Cappuccilli, Alessandra Spazzoli, et al.
Journal of Clinical Medicine|August 26, 2022
Efficacy of SARS-CoV-2 Vaccination in Dialysis Patients: Epidemiological Analysis and Evaluation of the Clinical ProgressGiovanni Mosconi, Michela Fantini, Matteo Righini, et al.
Pathogens (Basel, Switzerland)|October 23, 2021
Persistence of Antibody Responses to the SARS-CoV-2 in Dialysis Patients and Renal Transplant Recipients Recovered from COVID-19Maria Cappuccilli, Paolo Ferdinando Bruno, Alessandra Spazzoli, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|September 27, 2014
Post-dilution hemodiafiltration with a heparin-grafted polyacrylonitrile membraneGiovanni M Frascà, Sibilla Sagripanti, Mario D'Arezzo, et al.
Journal of Nephrology|November 13, 2023
Primary membranous nephropathy in the Italian region of Emilia Romagna: results of a multicenter study with extended follow-upVittorio Albertazzi, Francesco Fontana, Stefania Giberti, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 30, 2021
Ramipril and Cardiovascular Outcomes in Patients on Maintenance Hemodialysis: The ARCADIA Multicenter Randomized Controlled TrialPiero Ruggenenti, Manuel Alfredo Podestà, Matias Trillini, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Blood Purification|November 2, 2022
Anti-Inflammatory Approach in Chronic Dialysis Patients with SARS-CoV-2: ATA or PMMA Dialyzers?Gabriele Donati, Lorenzo Gasperoni, Marianna Napoli, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 2, 2019
C5 Convertase Blockade in Membranoproliferative Glomerulonephritis: A Single-Arm Clinical TrialPiero Ruggenenti, Erica Daina, Alessia Gennarini, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|September 21, 2018
[Challenges and results of the PIRP project (Prevenzione della Insufficienza Renale Progressiva) of the Emilia-Romagna Region]Antonio Santoro, Dino Gibertoni, Paola Rucci, et al.
Journal of Nephrology|January 20, 2019
The PIRP project (Prevenzione Insufficienza Renale Progressiva): how to integrate hospital and community maintenance treatment for chronic kidney diseaseAntonio Santoro, Dino Gibertoni, Paola Rucci, et al.
Nephron|April 26, 2021
COVID-19 Infection: Viral Clearance and Antibody Response in Dialysis Patients and Renal Transplant RecipientsPaolo Ferdinando Bruno, Maria Cappuccilli, Alessandra Spazzoli, et al.
Journal of Clinical Medicine|August 26, 2022
Efficacy of SARS-CoV-2 Vaccination in Dialysis Patients: Epidemiological Analysis and Evaluation of the Clinical ProgressGiovanni Mosconi, Michela Fantini, Matteo Righini, et al.
Pathogens (Basel, Switzerland)|October 23, 2021
Persistence of Antibody Responses to the SARS-CoV-2 in Dialysis Patients and Renal Transplant Recipients Recovered from COVID-19Maria Cappuccilli, Paolo Ferdinando Bruno, Alessandra Spazzoli, et al.
Therapeutic Apheresis and Dialysis : Official Peer-Reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy|September 27, 2014
Post-dilution hemodiafiltration with a heparin-grafted polyacrylonitrile membraneGiovanni M Frascà, Sibilla Sagripanti, Mario D'Arezzo, et al.
Journal of Nephrology|November 13, 2023
Primary membranous nephropathy in the Italian region of Emilia Romagna: results of a multicenter study with extended follow-upVittorio Albertazzi, Francesco Fontana, Stefania Giberti, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 30, 2021
Ramipril and Cardiovascular Outcomes in Patients on Maintenance Hemodialysis: The ARCADIA Multicenter Randomized Controlled TrialPiero Ruggenenti, Manuel Alfredo Podestà, Matias Trillini, et al.
Pageof 3